The short answer
Kolbaev and colleagues examined the effect of Semax on intracellular calcium dynamics in rat brain neurons, published in the Bulletin of Experimental Biology and Medicine in August 2025. This is a different and faster level of mechanism than the neurotrophin expression literature.
Key facts
- Study
- Kolbaev 2025 (PMID 41171324)
- Journal
- Bull Exp Biol Med, August 2025
- Preparation
- Rat brain neurons
- Measured
- Intracellular calcium dynamics
- Timescale
- Seconds to minutes
- Contrast
- Gene expression acts over hours
Why calcium is a useful readout
Intracellular calcium concentration is one of the most general signalling variables a neuron has. It changes within seconds of a stimulus, it is measurable in living cells with fluorescent indicators, and it sits upstream of a great many downstream processes. A compound that alters calcium dynamics is doing something at the level of immediate cell signalling.
Why this differs from the neurotrophin work
The existing Semax literature centres on expression of neurotrophins such as BDNF and NGF, a transcriptional readout operating over hours. Calcium operates over seconds. These are not competing accounts; they are different levels of a potential causal chain, and a fast signalling event is the kind of thing that could sit upstream of a slower transcriptional one.
Research material referenced
Semax 10mg, third-party HPLC tested
Why a fast readout is analytically valuable
Expression changes measured hours after exposure leave a long interval in which many things could intervene. An effect appearing within seconds in isolated neurons is much harder to attribute to anything other than the compound present, which narrows the causal question considerably even without identifying a receptor.
What it does not establish
A receptor, or a behavioural consequence. Altered calcium dynamics in rat brain neurons is a cellular observation. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones. It narrows the question rather than answering it.
Where the publication sits
The Bulletin of Experimental Biology and Medicine is a Russian journal, and the Semax literature is substantially Russian in origin, a point the existing literature article on this site makes. That is context for interpretation rather than a dismissal: the language and location of publication are not measures of quality, and limited independent replication outside that tradition is a real and separate limitation.
Regulatory position
Semax holds no marketing authorisation from the MHRA, EMA or FDA. Registration in another jurisdiction does not alter that, and material supplied here is for laboratory research only with no claim about any effect in any person.
Frequently asked questions
What did the 2025 study measure?
Intracellular calcium dynamics in rat brain neurons following Semax exposure, which is a cellular signalling readout.
How does that relate to the BDNF work?
Different timescales. Calcium changes within seconds; gene expression over hours. A fast event could sit upstream of a slower transcriptional one.
Does it identify a receptor?
No. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedKolbaev SN et al., The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons. Bull Exp Biol Med 2025 (PMID 41171324)pubmed.ncbi.nlm.nih.gov
- PubMedGlazova NY et al., Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations. Neuropeptides 2021 (PMID 33418449)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Semax (ACTH Fragment Peptide) articles
- What the Animal Behavioural Work ReportsGlazova 2021 examined Semax against alterations following early-life fluvoxamine exposure in rats. Why the model design is the interesting part.
- What a Fragment Keeps Decides What It DoesThree fragments of alpha-MSH pursue pigmentation, inflammation and cognition. The difference is not the parent - it is which residues each retained.
- What Is Semax? Origin, Sequence and Neurotrophin MechanismSemax is a synthetic heptapeptide derived from an ACTH fragment, developed in Russia. Structure, neurotrophin mechanism and regulatory status.
- Is Semax Really an ACTH(4-10) Analogue?Semax is universally called an ACTH(4-10) analogue, but shares only residues 4-7. Pro-Gly-Pro replaces Arg-Trp-Gly, and that substitution is the point.
- Semax Structure, Sequence and Physical PropertiesSemax is MEHFPGP, 7 residues, 813.9 Da, C37H51N9O10S. Sequence features, the two prolines, the single methionine, and what each means for handling.